Nava Limited (NAVA) Fair Value & Analysis

Industrials · IN · Market cap ₹158B

A solid business, currently priced close to our fair value.

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

• The price sits close to our fair value, market and models broadly agree here, little valuation tension.
• A fairly wide model range (₹309.68 to ₹728.70) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 22, 2026.

How to read this chart

60‑month range ₹31.40 – ₹724.87 · fair‑value band ₹309.68 – ₹728.70 · the ₹558.90 price screens above the ₹542.69 fair value. Dashed = 300-day average. As of Aug 22, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Nava Limited (NAVA) currently trades at ₹558.90, while our model-based Fair Value estimate is ₹542.69, implying the stock looks roughly 2.9% fairly valued today. The Quality Score stands at 57/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Nava Limited generated revenue of ₹42.9B at a net margin of 18.3%. Revenue grew 12.2% year over year. It earns a return on equity of 10.3%. Net debt stands at ₹1.2B. Fundamentals as of Aug 22, 2026

Our scenario range runs from ₹309.68 (bear case) to ₹728.70 (bull case); at ₹558.90, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 24% below its 52-week high and 12% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at 11% fair-value upside, at -3%, NAVA screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: DCF Models (₹487.78) versus Asset-Based (₹206.77). Highest evidence: Growth DCF (80).

Key figures & financial health

Quality Score breakdown

About the company

Nava Limited engages in the ferro alloys, power, mining, and healthcare businesses in India and internationally. It operates through Ferro Alloys, Power, and Mining Segment. It generates and sells power using coal, biomass, biogas, and bagasse.

Full company description

Nava Limited engages in the ferro alloys, power, mining, and healthcare businesses in India and internationally. It operates through Ferro Alloys, Power, and Mining Segment. It generates and sells power using coal, biomass, biogas, and bagasse. The company operates 150 MW and 114 MW coal-fired power plants in Paloncha, Telangana; 150 MW coal-fired power plant in Kharagprasad, Odisha; 20 MW and 9MW bagasse power plant in Dharmavaram and samalkot, Andhra Pradesh; and 300 MW thermal power plant in Zambia. It also mines coal at Maamba in Southern province of Zambia, as well as provides operation and maintenance services for power plants. In addition, the company provides various alloy metals, such as ferro and silico manganese that are used in automotive, railways, and construction industries, as well as in the manufacture of stainless-steel consumer goods. Further, it operates a medical clinic for the management of iron deficiency and the administration of intravenous iron in Singapore; and in-licenses pharmaceutical products. Additionally, the company engages in the agriculture business. The company was formerly known as Nava Bharat Ventures Limited and changed its name to Nava Limited in July 2022. Nava Limited was incorporated in 1972 and is based in Hyderabad, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Nava Limited reported revenue of ₹42.7B in FY2026 versus ₹33.1B in FY2022, a compound +6.5%/yr. Reported net income was ₹7.9B in FY2026, compounding +11.0%/yr from FY2022.

Watch NAVA: get an alert when its fair value changes →

Peer Group

Conglomerates · 388 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation Multiples vs Conglomerates median · lower = cheaper

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Aug 22, 2026).

Explore undervalued stocks

More undervalued Industrials stocks →

Discover undervalued stocks

Pick a strategy and jump into the live analysis with that exact screen applied.

Discover tools

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.